review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Guengerich FP | |
P2860 | cites work | Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme | Q24297544 |
Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B-specific monoclonal antibody | Q24302426 | ||
cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties | Q24647273 | ||
High-resolution crystal structure of cytochrome P450cam | Q27728724 | ||
Glutathione | Q28261279 | ||
Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney | Q28273910 | ||
Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase | Q28292662 | ||
Impaired oxidation of debrisoquine in patients with perhexiline neuropathy | Q28366143 | ||
cDNA and protein structure for the alpha subunit of human liver alcohol dehydrogenase | Q28633684 | ||
Oxidation of substituted N,N-dimethylanilines by cytochrome P-450: estimation of the effective oxidation-reduction potential of cytochrome P-450. | Q30458479 | ||
Molecular cloning of complementary DNA encoding the lignin-forming peroxidase from tobacco: Molecular analysis and tissue-specific expression | Q33238827 | ||
Transformation of thebaine to oripavine, codeine, and morphine by rat liver, kidney, and brain microsomes | Q33554609 | ||
Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence | Q33555966 | ||
N-methylation: potential mechanism for metabolic activation of carcinogenic primary arylamines | Q33566671 | ||
Proteins from eight eukaryotic cytochrome P-450 families share a segmented region of sequence similarity | Q33651405 | ||
Cloning and sequencing of a cDNA for a ligninase from Phanerochaete chrysosporium | Q34050204 | ||
Role of molecular oxygen in lignin peroxidase reactions | Q34050655 | ||
Arachidonic acid-dependent metabolism of 7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by ram seminal vesicles | Q43448200 | ||
Transformations of arylpropane lignin model compounds by a lignin peroxidase of the white-rot fungus Phanerochaete chrysosporium | Q43459645 | ||
Characterization of the omega-hydroxylase of Pseudomonas oleovorans as a nonheme iron protein | Q43500009 | ||
Peroxidase-catalyzed N-demethylation reactions: deuterium solvent isotope effects | Q43583524 | ||
Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses | Q43705605 | ||
Separation of two monoamine oxidases from bovine bran | Q44412462 | ||
A single amino acid substitution converts cytochrome P450(14DM) to an inactive form, cytochrome P450SG1: complete primary structures deduced from cloned DNAS. | Q44418687 | ||
Effect of substrate on the spin state of cytochrome P-450 in hepatic microsomes | Q45182076 | ||
Spectral intermediates in the reaction of oxygen with purified liver microsomal cytochrome P-450 | Q45196209 | ||
Interactions of diethylphenylphosphine with purified, reconstituted mouse liver cytochrome P-450 monooxygenase systems | Q45232704 | ||
Degradation of rat hepatic cytochrome P-450 heme by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine to irreversibly bound protein adducts. | Q45996347 | ||
Oxidation of (+)-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by mouse keratinocytes: evidence for peroxyl radical- and monoxygenase-dependent metabolism | Q46730711 | ||
Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence | Q48325388 | ||
Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase | Q48681443 | ||
Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N[2(ochlorophenoxy)-ethyl]-cyclopropylamine | Q49141001 | ||
The P450 gene superfamily: recommended nomenclature. | Q50709368 | ||
Purification of the flavin-containing monooxygenase from mouse and pig liver microsomes. | Q50925338 | ||
The purification of pig brain mitochondrial monoamine oxidase. | Q51189508 | ||
The sub-mitochondrial localization of monoamine oxidase in rat liver and brain. | Q51224402 | ||
Covalent binding to apoprotein is a major fate of heme in a variety of reactions in which cytochrome P-450 is destroyed. | Q51806191 | ||
On the mechanism of the peroxidase-catalyzed oxygen-transfer reaction. | Q52590651 | ||
Stopped-flow studies on the mechanism of oxidation of N-methyl-4-phenyltetrahydropyridine by bovine liver monoamine oxidase B. | Q52594583 | ||
3-Phenylpropenes as mechanism-based inhibitors of dopamine beta-hydroxylase: evidence for a radical mechanism. | Q52671978 | ||
Reducing substrate activity of some aromatic amines for prostaglandin H synthase. | Q53530709 | ||
Prostaglandin H synthase-dependent epoxidation of aflatoxin B1. | Q53542844 | ||
Prostaglandin H synthase-dependent co-oxygenation of (+/-)-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene in hamster trachea and human bronchus explants. | Q53551773 | ||
Purification of mixed-function amine oxidase from rat liver microsomes. | Q53561036 | ||
Mechanism for reactivation of N-cyclopropylbenzylamine-inactivated monoamine oxidase by amines. | Q53741439 | ||
A new spectral intermediate associated with cytochrome P-450 function in liver microsomes. | Q53876638 | ||
3-(Trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine photolabels a substrate-binding site of rat hepatic cytochrome P-450 form PB-4. | Q54423911 | ||
Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. | Q55060683 | ||
Dopamine beta-hydroxylase of adrenal chromaffin granules: structure and function | Q34164175 | ||
Biochemistry of metallothionein | Q34164847 | ||
Prostaglandin H synthase: distinct binding sites for cyclooxygenase and peroxidase substrates | Q34167660 | ||
Oxotransition metal oxidants as mimics for the action of mixed-function oxygenases. "NIH shift" with chromyl reagents | Q34235771 | ||
Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases | Q34256779 | ||
Aldehyde dehydrogenase from human liver. Primary structure of the cytoplasmic isoenzyme | Q34267380 | ||
Purification and characterization of cysteine conjugate transaminases from rat liver | Q34556957 | ||
Ferric chloride-catalyzed activation of hydrogen peroxide for the demethylation of N,N-dimethylaniline, the epoxidation of olefins, and the oxidative cleavage of vicinal diols in acetonitrile: a reaction mimic for cytochrome P-450 | Q34607001 | ||
Metabolism of aromatic amines by prostaglandin H synthase | Q35035594 | ||
cDNA and complete amino acid sequence of mouse P2(450): allelic variant of mouse P3(450) gene | Q35050194 | ||
Flavin and 5-deazaflavin: A chemical evaluation of ‘modified’ flavoproteins with respect to the mechanisms of redox biocatalysis | Q35555132 | ||
Substrate free radicals are intermediates in ligninase catalysis | Q35607625 | ||
Presence and formation of codeine and morphine in the rat | Q35612868 | ||
The possibility that the spectrum of intermediate two, seen in the course of reaction of flavoenzyme phenol hydroxylases, may be attributable to iminol isomers of a flavin-derived 6-arylamino-5-oxo(3H,5H)uracil | Q36246601 | ||
Cytochrome P-450 related to P-4504 from phenobarbital-treated rabbit liver: molecular cloning of cDNA and characterization of cytochrome P-450 obtained by its expression in yeast cells | Q36283602 | ||
Human dopamine beta-hydroxylase gene: two mRNA types having different 3'-terminal regions are produced through alternative polyadenylation | Q36417592 | ||
Crystallization of cytochrome P-450scc from bovine adrenocortical mitochondria | Q36452949 | ||
Complete amino acid sequence and predicted membrane topology of phenobarbital-induced cytochrome P-450 (isozyme 2) from rabbit liver microsomes | Q37521927 | ||
Stabilization of higher-valent states of iron porphyrin by hydroxide and methoxide ligands: electrochemical generation of iron(IV)-oxo porphyrins | Q37522188 | ||
Morphine and other opiates from beef brain and adrenal | Q37526607 | ||
On the mechanisms of induction of cancer-protective enzymes: a unifying proposal | Q37558012 | ||
Isolation of morphine from toad skin | Q37681014 | ||
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity | Q37683630 | ||
Interactions of monoamine oxidase with substrates and inhibitors | Q38601497 | ||
The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci | Q38618586 | ||
Characterization of human microsomal cytochrome P-450 enzymes | Q38639934 | ||
Comparison of the metabolism of benzo[a]pyrene and binding to DNA caused by rat liver nuclei and microsomes | Q39081155 | ||
Cytochrome P450 as an oxene transferase | Q39102085 | ||
Changes of mechanisms and product distributions in the hydrolysis of benzo[a]pyrene-7,8-diol 9,10,-epoxide metabolites induced by changes in pH | Q39155872 | ||
Destruction of heme and hemoproteins mediated by liver microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase | Q39207182 | ||
Highly purified microsomal P-450: The oxyferro intermediate stabilized at low temperature | Q39267690 | ||
Pharmacogenetics of methylation: relationship to drug metabolism | Q39518037 | ||
DNA repair in genes | Q39542919 | ||
Endogenous substrates for UDP-glucuronosyltransferases | Q39609883 | ||
Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). | Q39643835 | ||
The metabolic basis for combination chemotherapy | Q39652688 | ||
Flavin-containing monooxygenases: catalytic mechanism and substrate specificities | Q39654203 | ||
P450 genes: structure, evolution, and regulation | Q39664988 | ||
Metabolism and reactions of alkylating agents | Q39691866 | ||
Kinetic isotope effects and 'metabolic switching' in cytochrome P450-catalyzed reactions | Q39693446 | ||
Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism | Q39733913 | ||
An update on the identity crisis of monoamine oxidase: new and old evidence for the independence of MAO A and B. | Q39843930 | ||
Enzymatic activation of chemicals to toxic metabolites. | Q39847955 | ||
Isolation from bovine liver mitochondria of a soluble ferredoxin active in a reconstituted steroid hydroxylation reaction | Q40096645 | ||
Vitamin D: recent advances | Q40137018 | ||
Chemical Mechanisms of Halocarbon Metabolism | Q40147765 | ||
Suicidal destruction of cytochrome P-450 during oxidative drug metabolism | Q40152926 | ||
Xenobiotic metabolism by prostaglandin endoperoxide synthetase | Q40210070 | ||
Models for ferric cytochrome P450. Characterization of hemin mercaptide complexes by electronic and ESR spectra | Q40275383 | ||
Oxygen activation by cytochrome P-450. | Q40289289 | ||
Oxygenase-catalyzed biological hydroxylations | Q40690254 | ||
Differences in mutagenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides | Q40808035 | ||
Nuclear Activation of Polycyclic Hydrocarbons | Q41201277 | ||
Prostagland in synthetase dependent benzo(a)pyrene oxidation: Products of the oxidation and inhibition of their formation by antioxidants | Q41346686 | ||
Lignin peroxidase: resonance Raman spectral evidence for compound II and for a temperature-dependent coordination-state equilibrium in the ferric enzyme | Q41372672 | ||
4-alkyl radical extrusion in the cytochrome P-450-catalyzed oxidation of 4-alkyl-1,4-dihydropyridines | Q41408857 | ||
Inactivation of dopamine beta-hydroxylase by p-cresol: isolation and characterization of covalently modified active site peptides | Q41418608 | ||
Iodosylbenzene derivatives as oxygen donors in cytochrome P-450 catalyzed steroid hydroxylations | Q41439521 | ||
Synthesis of the skeleton of the morphine molecule by mammalian liver | Q41466253 | ||
Determination of the membrane topology of the phenobarbital-inducible rat liver cytochrome P-450 isoenzyme PB-4 using site-specific antibodies | Q41514139 | ||
Olefin oxidation by cytochrome P-450: evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene | Q41589786 | ||
Oxidation of trichloroethylene by liver microsomal cytochrome P-450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide | Q41620925 | ||
25-Hydroxylation of vitamin D3 by a cytochrome P-450 from rabbit liver mitochondria | Q42164193 | ||
Participation of cytochrome P-450 isozymes in N-demethylation, N-hydroxylation and aromatic hydroxylation of methamphetamine | Q42209001 | ||
Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine | Q42209031 | ||
Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae | Q42216518 | ||
A genetic polymorphism of the N-oxidation of trimethylamine in humans | Q42220150 | ||
Inactivation of cytochrome P-450 by 2-isopropyl-4-pentenamide and other xenobiotics leads to heme-derived protein adducts. | Q42221739 | ||
Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). | Q42224907 | ||
Characterization of the enzymatic and nonenzymatic peroxidative degradation of iron porphyrins and cytochrome P-450 heme | Q42226013 | ||
Carbon tetrachloride and 2-isopropyl-4-pentenamide-induced inactivation of cytochrome P-450 leads to heme-derived protein adducts | Q42226618 | ||
Destruction of cytochrome P-450 by vinyl fluoride, fluroxene, and acetylene. Evidence for a radical intermediate in olefin oxidation | Q42241514 | ||
Chemical Mutation of Enzyme Active Sites | Q42244435 | ||
Metabolic activation of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide by prostaglandin H synthase | Q42249301 | ||
Rabbit lung flavin-containing monooxygenase is immunochemically and catalytically distinct from the liver enzyme | Q42249402 | ||
Effect of alpha-methylation on inactivation of monoamine oxidase by N-cyclopropylbenzylamine | Q42250963 | ||
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis | Q42255167 | ||
Dopamine-B-hydroxylase: suicide inhibition by the novel olefinic substrate, 1-phenyl-1-aminomethylethene | Q42259898 | ||
Alkylation of the prosthetic heme in cytochrome P-450 during oxidative metabolism of the sedative-hypnotic ethchlorvynol | Q42265519 | ||
Prostaglandin hydroperoxidase-catalyzed activation of certain N-substituted aryl renal and bladder carcinogens | Q43235620 | ||
P433 | issue | 2 | |
P304 | page(s) | 97-153 | |
P577 | publication date | 1990-01-01 | |
P1433 | published in | Critical Reviews in Biochemistry and Molecular Biology | Q5186661 |
P1476 | title | Enzymatic oxidation of xenobiotic chemicals | |
P478 | volume | 25 |
Q41892368 | 35 Cytochrome P450 expression and metabolism in isolated rabbit renal epithelium |
Q36646897 | A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBP beta and an Sp1 factor |
Q28367968 | A single cytochrome P-450 system is involved in degradation of the herbicides EPTC (S-ethyl dipropylthiocarbamate) and atrazine by Rhodococcus sp. strain NI86/21 |
Q35815650 | Aldehyde dehydrogenases and their role in carcinogenesis |
Q42705895 | Aldrin epoxidation in flathead mullet (Mugil cephalus): possible involvement of CYP1A and CYP3A. |
Q34302711 | An insight into the origin and functional evolution of bacterial aromatic ring-hydroxylating oxygenases |
Q46549147 | Attenuation of hyperoxic lung injury by the CYP1A inducer beta-naphthoflavone |
Q41137512 | Biochemical basis of hepatocellular injury |
Q47735645 | Biomonitoring of arylamines: haemoglobin adducts of aniline derivatives |
Q44483712 | Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver |
Q39799211 | Characterization of the expression of the thcB gene, coding for a pesticide-degrading cytochrome P-450 in Rhodococcus strains |
Q33501831 | Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization |
Q34612118 | Cytochrome P450 polymorphisms and response to antipsychotic therapy. |
Q43825182 | Cytogenetic study of chronic ethanol consumption in rats |
Q44274613 | Degradation of an alkaloid pheromone from the pale-brown chafer, Phyllopertha diversa (Coleoptera: Scarabaeidae), by an insect olfactory cytochrome P450. |
Q39642645 | Degradation of morpholine by an environmental Mycobacterium strain involves a cytochrome P-450. |
Q35578764 | Degradation of the thiocarbamate herbicide EPTC (S-ethyl dipropylcarbamothioate) and biosafening by Rhodococcus sp. strain NI86/21 involve an inducible cytochrome P-450 system and aldehyde dehydrogenase. |
Q35585218 | Desaturation, dioxygenation, and monooxygenation reactions catalyzed by naphthalene dioxygenase from Pseudomonas sp. strain 9816-4 |
Q48736017 | Disposition of Hexobarbitone and Antipyrine in DOCA-hypertensive Rats |
Q35566747 | Disruption of cytochrome P4501A2 in mice leads to increased susceptibility to hyperoxic lung injury |
Q78122290 | Dual targeting property of the N-terminal signal sequence of P4501A1. Targeting of heterologous proteins to endoplasmic reticulum and mitochondria |
Q43768879 | Effects of cysteine on the pharmacokinetics of intravenous phenytoin in rats with protein-calorie malnutrition |
Q34951334 | Engineered yeasts simulating P450-dependent metabolisms: tricks, myths and reality. |
Q51336924 | Gene cloning and characterization of aldehyde dehydrogenase from a petroleum-degrading bacterium, strain HD-1. |
Q44643518 | Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1α)-deficient mice |
Q28365626 | Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways |
Q34122409 | Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment |
Q67867130 | In vitrotransformation of dithiopyr by rat liver enzymes: Conversion of methylthioesters to acids by oxygenases |
Q77634762 | Inhibition and induction of cytochrome P450 and the clinical implications |
Q77703027 | Kinetic characterization of the inactivation of ammonia monooxygenase in Nitrosomonas europaea by alkyne, aniline and cyclopropane derivatives |
Q36316481 | Leflunomide Induces Pulmonary and Hepatic CYP1A Enzymes via Aryl Hydrocarbon Receptor |
Q28536701 | Malignant transformation potentials of human umbilical cord mesenchymal stem cells both spontaneously and via 3-methycholanthrene induction |
Q41651588 | Mechanism of benzo[a]pyrene-induced Cyp1a-1 gene expression in mouse Hepa 1c1c7 cells: Role of the nuclear 6 s and 4 s proteins |
Q28582020 | Membrane topology and cell surface targeting of microsomal epoxide hydrolase. Evidence for multiple topological orientations |
Q39857866 | Metabolism of the herbicide atrazine by Rhodococcus strains. |
Q34354194 | Mice deficient in the gene for cytochrome P450 (CYP)1A1 are more susceptible than wild-type to hyperoxic lung injury: evidence for protective role of CYP1A1 against oxidative stress |
Q79175571 | Molecular mechanism of the enzymatic oxidation investigated for imidazoacridinone antitumor drug, C-1311 |
Q48286870 | Multiplicity and tissue specific expression of camel cytochrome P450(s). |
Q34818942 | N-oxidative transformation of free and N-substituted amine functions by cytochrome P450 as means of bioactivation and detoxication |
Q36672374 | Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer |
Q44564177 | Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation |
Q35265520 | Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes |
Q33742250 | On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerations |
Q40372746 | On the mechanism of amine oxidations by P450. |
Q35189845 | Oxidation of 6,7-dihydro-5H-benzocycloheptene by bacterial strains expressing naphthalene dioxygenase, biphenyl dioxygenase, and toluene dioxygenase yields homochiral monol or cis-diol enantiomers as major products |
Q47245449 | Oxygen Activation and Radical Transformations in Heme Proteins and Metalloporphyrins |
Q28138121 | P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues |
Q36554803 | Partial Characterization of the Human CYP1A1 Negatively Acting Transcription Factor and Mutational Analysis of Its Cognate DNA Recognition Sequence |
Q28387997 | Persistent induction of hepatic and pulmonary phase II enzymes by 3-methylcholanthrene in rats |
Q77384684 | Phytooxylipins and plant defense reactions |
Q45559638 | Polymorphisms of Glutathione-S-Transferase Genes and the Risk of Aerodigestive Tract Cancers in the Northeast Indian Population |
Q35381595 | Prenatal administration of the cytochrome P4501A inducer, Β-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants |
Q40372739 | Radical cation intermediates in N-dealkylation reactions |
Q40824955 | Rainbow trout cytochrome P450s: purification, molecular aspects, metabolic activity, induction and role in environmental monitoring |
Q35062472 | Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors |
Q37368782 | Roles of UDP-glucuronosyltransferases in chemical carcinogenesis |
Q28593237 | Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes |
Q34362352 | Sex-specific differences in hyperoxic lung injury in mice: implications for acute and chronic lung disease in humans |
Q40949921 | Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives |
Q39797157 | Stabilization of microbial cytochrome P-450 activity by creation of station-phase conditions in a continuously operated immobilized-cell reactor. |
Q24533519 | Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily |
Q74270688 | The DWF4 gene of Arabidopsis encodes a cytochrome P450 that mediates multiple 22alpha-hydroxylation steps in brassinosteroid biosynthesis |
Q37074005 | The Role of Peroxidases in the Activation of Chemical Carcinogens |
Q43881829 | The effect of age on inducibility of various types of rat liver cytochrome P-450 |
Q46671828 | The functional expression of sodium-dependent bile acid transport in Madin-Darby canine kidney cells transfected with the cDNA for microsomal epoxide hydrolase |
Q36258518 | The human hepatic cytochromes P450 involved in drug metabolism |
Q41571797 | The impact of GSTM1/GSTT1 polymorphism for the risk of oral cancer |
Q40600037 | The metabolism of alicyclic amines to reactive iminium ion intermediates |
Q28379109 | Toluene and ethylbenzene oxidation by purified naphthalene dioxygenase from Pseudomonas sp. strain NCIB 9816-4 |
Q38039138 | Toxicological actions of plant-derived and anthropogenic methylenedioxyphenyl-substituted chemicals in mammals and insects |
Q34906502 | Transformation of Mouse Liver Cells by Methylcholanthrene Leads to Phenotypic Changes Associated with Epithelial-mesenchymal Transition. |
Q39915133 | Transformations of Aromatic Compounds by Nitrosomonas europaea |
Q33966583 | UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer |
Search more.